SCP
BVS icon

Seizert Capital Partners’s Bioventus BVS Stock Holding History

Seizert Capital Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
34,893
+10,135
+41% +$96.8K 0.01% 160
2026
Q1 		$226K Hold
24,758
– – 0.01% 163
2025
Q4 		$184K Hold
24,758
– – 0.01% 175
2025
Q3 		$166K Hold
24,758
– – 0.01% 168
2025
Q2 		$164K Buy
24,758
+9,875
+66% +$70K 0.01% 169
2025
Q1 		$136K Hold
14,883
– – 0.01% 156
2024
Q4 		$156K Buy
+14,883
New +$176K 0.01% 160

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Seizert Capital Partners's BVS Position: Q2 2026 in Review

Seizert Capital Partners increased its Bioventus (BVS) stake by 41% in Q2 2026, buying an estimated $96.8K and bringing the position to 34,893 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #160.

Seizert Capital Partners first reported a position in BVS in Q4 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Seizert Capital Partners held 34,893 shares of Bioventus worth $329K as of Q2 2026.
  • Seizert Capital Partners bought 10,135 Bioventus shares in Q2 2026, an estimated $96.8K.
  • Bioventus made up 0.01% of Seizert Capital Partners's portfolio in Q2 2026, its #160 holding.
  • Seizert Capital Partners first reported a position in Bioventus in Q4 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Seizert Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.